Natera <>, a maker of non-invasive prenatal tests, has reached the lowest level since April 2020 on Wednesday after Hindenburg Research released a short report alleging, among…

So What's Happening With Natera Shares?

03:48pm, Wednesday, 09'th Mar 2022
Natera Inc (NASDAQ: NTRA) shares are trading lower by 31.2% at $37.66 after Hindenburg Research issued a short report on the stock. Hindenburg Research stated, "Based on more than 2 dozen interviews w
Shares of Natera Inc. NTRA, -32.05% plummeted 32.9% in active afternoon trading Wednesday toward a 22-month low, enough to pace all of the Nasdaq's decliners, after noted short seller Hindenburg Resea

Natera plunges on new short call from Hindenburg Research

01:24pm, Wednesday, 09'th Mar 2022 Seeking Alpha
Natera Inc. (NTRA) dropped 15% in premarket trading after Hindenburg Research released a new short report on the prenatal testing companyHindenburg alleges that Natera''s revenue growth…

Why Is Natera (NTRA) Stock Down Today?

12:23pm, Wednesday, 09'th Mar 2022
NTRA stock has lost more than 35% following a short report by Hindenburg Research. The report alleges fraud, among other claims.

Analyst Ratings For Natera

04:03pm, Tuesday, 08'th Mar 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Natera (NASDAQ:NTRA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company'

Analyst Ratings For Natera

04:03pm, Tuesday, 08'th Mar 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Natera (NASDAQ: NTRA ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 3 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Natera has an average price target of $104.5 with a high of $118.00 and a low of $90.00. Below … Full story available on Benzinga.com
Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth quarter, compared to
Minneapolis, March 08, 2022 (GLOBE NEWSWIRE) -- Today, Tues., March 8, and throughout the month, civic, public, and private buildings and landmarks across the United States are slated to go BLUE (the awareness color for colorectal cancer) in honor of the nation''s colorectal cancer (CRC) community, including over one million colorectal cancer survivors. March is Colorectal Cancer Awareness Month. Minnesota-based Colon Cancer Coalition is leading the effort with help from Fight Colorectal Cancer, and countless volunteers, with the support of sponsors Bayer and Natera. Throughout Colorectal Cancer Awareness Month, over 200 landmarks, health care communities, and private businesses are confirmed to "go blue" with either lights or awareness efforts. The bulk of landmarks are slated to be blue from dusk to dawn on Tues., March 8. In addition, businesses and health care facilities are encouraging employees and patients to wear blue, share information, and encourage screening for the nation''s no. 2 cancer killer.
Natera, Inc. (NTRA) CEO Steve Chapman on Q4 2021 Results - Earnings Call Transcript

Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates

11:50pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Natera (NTRA) delivered earnings and revenue surprises of -19.35% and 2.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Natera: Q4 Earnings Snapshot

10:44pm, Thursday, 24'th Feb 2022 mySA
AUSTIN, Texas (AP) _ Natera Inc. (NTRA) on Thursday reported a loss of $140.6 million in its fourth quarter. The Austin, Texas-based company said it had a loss of $1.48 per share. The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share. The genetic testing company posted revenue of $173 million in the period, topping Street forecasts. Five analysts surveyed by Zacks expected $168.2 million. For the year, the company reported that its loss widened to $471.7 million, or $5.21 per share. Revenue was reported as $625.5 million. Natera expects full-year revenue in the range of $770 million to $790 million. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NTRA at https://www.zacks.com/ap/NTRA

Natera, Inc. 2021 Q4 - Results - Earnings Call Presentation

09:34pm, Thursday, 24'th Feb 2022 Seeking Alpha
Natera press release (NTRA): Q4 GAAP EPS of -$1.48 misses by $0.18.Revenue of $173M (+53.9% Y/Y) beats by $4.19M.Outlook:Natera anticipates 2022 total revenue of $770 million to…
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE